KFDA maps out preclinical guidelines on child-specific medicines

The Korea Food and Drug Administration said it will publish its preclinical guidelines on child-specific medicines as more interest has focused on their development in recent years.

We have drawn up the guideline as part of moves to encourage pharmaceutical firms to develop child medicines, said a KFDA official.

"Children metabolize differently from adults. They therefore need different d...